| 6411 |
表1：世卫组织医疗产品警报2019 年第11 期所涉伪造的奥格门汀和阿莫西林克拉维酸钾产品详情 |
Table 1: Details of the falsified product Augmentin and Amoxicillin Clavulanate Potassium, subject of WHO medical product alert N°11/2019 |
|
| 6412 |
以上所称生产商已确认： |
The above stated manufacturer has confirmed that: |
|
| 6413 |
未曾生产该伪造版本。 |
They did not manufacture this falsified version. |
|
| 6414 |
产品标签上的可变细节与正规生产商记录不符。 |
The variable details on the product label do not correspond to the genuine manufacturing records. |
|
| 6415 |
标签和包装存有不一致情况。 |
There are labelling and packaging inconsistencies. |
|
| 6416 |
还应指出的是： |
It should also be noted that: |
|
| 6417 |
在现阶段，世卫组织没有收到不良反应报告。 |
At this stage, no adverse reactions have been reported to WHO. |
|
| 6418 |
2. Bactoclav |
2. |
|
| 6419 |
表2：世卫组织医疗产品警报2019 年第11 期所涉伪造的Bactoclav 产品详情 |
Table 2: Details of the falsified product Bactoclav, subject of WHO medical product alert N°11/2019 |
|
| 6420 |
应指出的是： |
It should be noted that: |
|